Formulation and clinical evaluation of hydrogel containing bisabolol nanocapsules for treatment of dermatitis

Phase 2

• Conditions: Eczema.; Intrinsic (allergic) eczema; L20.84

• Registration Number: IRCT20200115046143N2
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 12 July 2021

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Chronic eczema of the hand

Exclusion Criteria

Pregnancy or breastfeeding
Other concurrent skin lesions such as psoriasis
Immunodeficiency

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The severity of pruritus. Timepoint: Before the intervention and 2 and 6 weeks after the intervention. Method of measurement: By taking history.;The severity of skin lesions. Timepoint: Before the intervention and 2 and 6 weeks after the intervention. Method of measurement: By clinical examination.